Notably, the predictor set for DLCO (HB-EGF, MCP-4, Fibrinogen, sRAGE and Sortilin) predicted a substantial percentage of COPD subject variability in the test set with a median value of 21%. This evidence concerns the gene CCL13 and chronic obstructive pulmonary disease.